2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …

…, G Kovacs, MM Hoeper, R Badagliacca… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

The overloaded right heart and ventricular interdependence

R Naeije, R Badagliacca - Cardiovascular research, 2017 - academic.oup.com
The right and the left ventricle are interdependent as both structures are nested within the
pericardium, have the septum in common and are encircled with common myocardial fibres. …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

…, G Kovacs, MM Hoeper, R Badagliacca… - European …, 2023 - Eur Respiratory Soc
Guidelines summarize and evaluate available evidence, with the aim of assisting health
professionals in proposing the best management strategies for an individual patient with a given …

Circulating biomarkers in pulmonary arterial hypertension: update and future direction

B Pezzuto, R Badagliacca, R Poscia, S Ghio… - The Journal of Heart and …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is a complex disease with a poor prognosis. In
recent years, great advances have occurred in our understanding of the pathophysiologic …

Syncope and risk of sudden death in hypertrophic cardiomyopathy

…, C Autore, C Rapezzi, P Bernabň, R Badagliacca… - Circulation, 2009 - Am Heart Assoc
Background— The prognostic significance of syncope has not been investigated systematically
in hypertrophic cardiomyopathy, and treatment strategies have been based largely on …

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial

…, A Amaducci, R Badagliacca, R Poscia… - The Journal of Heart and …, 2017 - Elsevier
Background Pulmonary hypertension (PH) is a well-known independent prognostic factor in
chronic obstructive pulmonary disease (COPD) and a sufficient criterion for lung transplant …

Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension

M D'Alto, R Badagliacca, P Argiento, E Romeo, A Farro… - Chest, 2020 - Elsevier
… predictive accuracy by means of r 2 . A quadratic model was identified as the most accurate.
Details of the quadratic model are reported, including corresponding r 2 values, P values, …

Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long‐term comparison

…, M Guazzi, R Badagliacca… - European journal of …, 2018 - Wiley Online Library
Aims Risk stratification in heart failure (HF) is crucial for clinical and therapeutic management.
A multiparametric approach is the best method to stratify prognosis. In 2012, the Metabolic …

[HTML][HTML] Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension …

…, T Lange, S Rosenkranz, D Dumitrescu, R Badagliacca… - Chest, 2021 - Elsevier
… Ardeschir Ghofrani MD c i , Matthias Held MD j , Hans Klose MD k , Tobias Lange MD l ,
Stephan Rosenkranz MD m , Daniel Dumitrescu MD n , Roberto Badagliacca MD a , Martin …

Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study

…, I Sciarra, CD Vizza, R Badagliacca, R Poscia… - …, 2013 - academic.oup.com
Objective. Pulmonary arterial hypertension (PAH) is a complication of SSc due to increased
vascular resistance, and abnormal vascularity is a well-known feature of the disease as …